Get started
Author

Ceyda Sönmez Wetherilt

Observed names: Ceyda Sonmez Wetherilt, Ceyda Wetherilt
ORCID: 0009-0002-5252-479X
Observed ORCID: 0009-0002-5252-479X
OpenAlex ID: A5082679883
Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer
2016 · Xiaoxian Li, Ceyda Sonmez Wetherilt, et al. · American Journal of Clinical Pathology · 93
Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor–positive breast cancers
2017 · Uma Krishnamurti, Ceyda Sonmez Wetherilt, et al. · Human Pathology · 80
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
2019 · Shristi Bhattarai, Sergey Klimov, et al. · Cancers · 74
PDF
Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
2017 · Angela Ogden, Chakravarthy Garlapati, et al. · Scientific Reports · 40
PDF
Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study
2025 · Zeliha Birsin, İsmail Nazlı, et al. · Journal of Clinical Medicine · 8
PDF
Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization
2016 · Nuray Kepil, Sebnem Batur, et al. · Bosnian Journal of Basic Medical Sciences · 5
PDF
Invasion prediction with artificial intelligence in ductal carcinoma in situ (DCIS) patients: a proof-of-concept study
2025 · Adnan Gundogdu, Ceyda Sonmez Wetherilt, et al. · BMC Surgery · 2
PDF
A multi-institutional study of racial differences in androgen receptor status among triple-negative breast cancers.
2016 · Shristi Bhattarai, Jun Xia, et al. · Journal of Clinical Oncology · 1
Pseudoangiomatous Stromal Hyperplasia of the Breast: Clinical, Radiologic and Histopathologic Spectrum in a Retrospective Single‐Centre Series
2026 · Sedef Mevlüde Karaböcek, Seda Aladag Kurt, et al. · Journal of Medical Imaging and Radiation Oncology
Occult Pathology in the Contralateral Prophylactic Mastectomy Specimen Despite a Negative Contralateral MRI: A Single-Center Cohort Study
2026 · Osman Cem Yılmaz, Adnan Gündoğdu, et al. · Cancers
A Subset of Cutaneous Melanoma Express Oncofetal Cripto-1 Protein: Correlation of Histopathology and Prognosis
2026 · Ayşe Mine Önenerk Men, Ayşe Hanım Namal, et al. · Cerrahpasa Medical Journal
PDF
AI-assisted digital breast tomosynthesis as a decision-support tool for post-neoadjuvant surgical planning in breast cancer
2026 · Adnan Gündoğdu, Nur Betül Ünal Özdemir, et al. · Langenbeck s Archives of Surgery
Does Surgical Timing After Neoadjuvant Anti‐HER2 Therapy Affect Pathological Complete Response and Survival in HER2‐Positive Breast Cancer? A Multicenter Retrospective Cohort Study
2026 · Zeliha Birsin, Onur Alkan, et al. · Journal of Surgical Oncology
PDF
Unmasking intratumoral heterogeneity: Postoperative revelation of subclonal divergence in de novo metastatic HR‑positive/HER2‑negative breast cancer: A case report
2026 · Zeliha Birsin, Emir Çerme, et al. · Molecular and Clinical Oncology
PDF
Role of Multiparametric Ultrasound in Determining the Presence of Tumor‐Infiltrating Lymphocytes in Invasive Breast Cancer
2025 · Yasemin Kayadibi, Gul Esen, et al. · Journal of Ultrasound in Medicine
PDF
Anterior and posterior vaginal wall thickness in women without genital prolapse
2025 · Cemal Tamer Erel, Ceyda Sonmez Wetherilt, et al. · Maturitas
Abstract PR18: Prognostic role of androgen receptor in triple-negative breast cancer: A global multi-institutional experience
2020 · Shristi Bhattarai, Sergey Klimov, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract PR02: β-Catenin overexpression underlies the aggressive disease course in African American triple-negative breast cancer patients who lack androgen receptor
2018 · Karuna Mittal, Shristi Bhattarai, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract B12: Racial differences in Androgen Receptor status among triple-negative breast cancers
2017 · Bhattarai Shristi, Jun Xia, et al. · Cancer Epidemiology Biomarkers & Prevention
A combined HER3-EGFR score in triple-negative breast cancer: racial differences.
2016 · Angela Ogden, Shristi Bhattarai, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 303
H-index: 5
I10-index: 4
Year
Topic
Type